Načítá se...
How is Herstatin, a tumor suppressor splice variant of the oncogene HER2, regulated?
The human epidermal growth factor receptor 2 (HER2)/receptor tyrosine-protein kinasebB-2 (ERBB2) is overexpressed in 20–30% of breast tumors leading to faster growing and more aggressive tumors. Alternative splicing generates a functionally distinct HER2 variant called Herstatin, which is produced b...
Uloženo v:
| Vydáno v: | RNA Biol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5449083/ https://ncbi.nlm.nih.gov/pubmed/27935425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15476286.2016.1267074 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|